ESR1 and breast carcinoma: Particularly, leptin may act by (i) binding its own receptor (ObR) or (ii) by interacting with other different mediators known to be involved in breast cancer biology (e.g., ERα, growth factors, Notch, and inflammatory cytokines) [40].